AU$ 5M in R&D tax credits + additional grant funding coming in hot + the SPV options that could certainly strike, I think they will be fine... FDA 510k is within 90 odd days now. The team will have enough cash in the coffers to get them over the line and should it come to the UNLIKELY case where they need a bandaid amount of funding between now and approval, the devil's phone is always there...
you are insinuating that the company is putting down traintracks metres infront of the head of a train like a looney tunes animation with a concept of 0 TV frames ahead... why is that the case? are you a bot?
gltah & go kangas
4DX Price at posting:
30.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)